ArticleDiabetes2005
Rosiglitazone reduces glucose-stimulated insulin secretion rate and increases insulin clearance in nondiabetic, insulin-resistant individuals.
Sun H Kim et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
21 papers cite it
this papertrialcites it